Interestingly, patient 17, who had the exacerbated humoral response, had zero IFNg spots both at baseline and at follow-up visits, suggesting that in his predominating humoral response, the activation of specific anti-tumor CD8+ T cells were inhibited or diminished. This evidence concerns the gene IFNG and neoplasm.